Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin glargine versus insulin detemir for appetite-related hormones in children with newly diagnosed type 1 diabetes
IRCT20191208045651N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in diabetes mellitus type 1 (T1D) comparing Insulin glargine with Insulin detemir (2 arms). Primary endpoint: Rate of factors affecting appetite. Started Apr 2019; status: completed.
02
Drugs
insulin glargineinsulin detemir
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on IRCT20191208045651N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191208045651N1.